RhoVac ApS

RhoVac is a biotechnology company conducting research and development in immunotherapy, more specifically – on therapeutic cancer vaccines. The company’s primary focus is to develop a drug with the potential to prevent or limit metastases in metastatic cancers.

Contact name:

Steffen Wad Jørgensen


c/o DTU Science Park, Agern Alle 24, 2970 Hørsholm, Denmark


+45 53 68 27 11



Number of employees:


If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact ps@danskbiotek.dk or +45 7172 1114

Copyright 2018 DANISH BIO – DANSK BIOTEK. All rights reserved.